Colossal Biosciences, a U.S.-based genetic engineering company, has announced significant progress in its ambitious endeavor to resurrect the extinct dodo bird. The company’s strategy centers on advanced gene-editing techniques, aiming to recreate dodo traits within the genome of the Nicobar pigeon, its closest living relative. Researchers are focusing on modifying the cells of the Nicobar pigeon to express characteristics of the long-lost dodo. This effort represents a significant leap forward in de-extinction technology and raises both scientific excitement and ethical considerations. Colossal Biosciences intends to ultimately create a bird that closely resembles the dodo, though it won’t be a perfect genetic replica. The project highlights the potential – and challenges – of using biotechnology to restore lost biodiversity.